World
WHO says Ebola vaccine trial starts in Congo outbreak
The Hindu·
The Democratic Republic of Congo began the Tumaini Ervebo vaccine trial in Bunia on October 23. WHO chief Tedros Adhanom Ghebreyesus said shots will test cross-protection against the Bundibugyo strain. The outbreak has passed 9,700 cases with more than 4,600 deaths. Oxford and Moderna candidates may join the ring vaccination study later under CEPI funding.
Prism
What It Means For You
- Health workers in Ituri province may see new vaccination rings around high-risk contacts in Bunia.
- Regional travellers should follow DRC health advisories as the outbreak exceeds 9,700 recorded cases.
- Vaccine researchers may watch Tumaini results before approving Bundibugyo-specific candidates.
What's Happening
- WHO said the first Ervebo doses were given in Bunia on October 23 under the Tumaini framework.
- Tedros posted on X that the trial means hope in Swahili and will test multiple candidates.
- Ervebo is approved for Zaire Ebola but not yet for Bundibugyo.
Bundibugyo strain vaccine gap
- The epidemic has recorded more than 4,600 deaths according to WHO reporting cited in coverage.
- Ring vaccination will target contacts deemed at high infection risk.
- Oxford and Moderna jabs funded by CEPI may enter the same trial later.
all-news
